Bill joined Royalty Pharma in 2021. Previously, he was a biotechnology equity research associate at Stifel Financial. Prior to Stifel, he worked in venture capital at XSEED Capital and in finance at Amgen.
Bill has a B.S. in Finance and Biochemistry form California Polytechnic State University. He completed his PhD in Chemistry at the University of Colorado, Boulder where he was an NIH Pharmaceutical Biotechnology Fellow.